Palmar-plantar erythrodysaesthesia syndrome secondary to 5-fluorouracil therapy: Successful treatment with pyridoxine;Sindrome de eritrodisestesia palmo-plantar por 5-fluorouracilo: Respuesta favorable al tratamiento con piridoxina

Medicina Cutanea Ibero-Latino-Americana

Volumn 26, Issue 1, 1998, Pages 35-38

  Nagore Enguídanos, Eduardo ^a   Sanchez Motilla J Ma ^a   Insa Molla A ^b   Febrer, Ma I ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

5 Fluorouracil; Hand foot disease; Palmar plantar erythrodysesthesia; Pyridoxine

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; PYRIDOXINE DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; COLON CARCINOMA; DISEASE SEVERITY; ERYTHEMA; FEMALE; FOOT; HAND; HUMAN; SKIN BIOPSY;

EID: 0039219015     PISSN: 02105187     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. LEVINE, N.; GREEVALD, E. S.: Mucocutaneous side effects of cancer chemotherapy. Cancer Treat Rev, 1978; 5: 67-84.
2. FELDMAN, L. D.; JAFFER, A.: Fluorouracil-associated pal mar-plantar erythrodysesthesia syndrome. JAMA, 1985; 254: 3479.
3. MORTIMER, J. E.; ANDERSON, I.: Weekly fluorouracil and high-dose leucovorin: efficacy and treatment of cutaneous toxicity. Cancer Chemother Pharmacol, 1990; 26: 449-452.
4. FABIAN, C. J.; MOLINA, R.; SLAVIK, M.; DAHLBERG, S.; GIRI, S.; stephens, R.: Piridoxine theraphy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion. Invest. New Drugs, 1990; 8: 57-63.
5. KOMAMURA, H.; HIGASHIYAMA, M.; HASHIMOTO, K.; TAKEDA, K.; kimura, H.; TANI, Y.; OGAWA, H.; YOSHIYAWA, K.: Three cases of chemotherapy-induced acral erythema. J Dermatol, 1995; 22: 116-121.
6. GUILLAUME, J. C.; CARP, E.; RONGIER, P.; CHARPENTIER, P.; ANDRÉ, P.; CARDE, P.; AVRIL, M. F.: Effects secondaries cutáneo-muqueux des perfusions continues de 5-fluorouracile: 12 observations. Ann Dermatol Venereol, 1988; 115: 1167-1169.
7. COHEN, P. R.: Acral Erythema: a clinical review. Cutis, 1993; 51: 175-9.
8. GORDON, K. B.; TAJUDDIN, A.; GUITART, J.; KUZEL, T. M.; ERAMO, L. R.; VON ROENN, J.: Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy. Cancer, 1995; 75: 2169-73.
9. HELLIER, I.; BESSIS, D.; SOTTO, A.; MARGUERITTE, G.; GUILHOU, J. J.: High-dose methrotrexate-induced bullous variant of acral erythema. Arch Dermatol, 1996; 132: 590-591.
10. COX, G. J.; ROBERTSON, D. B.: Toxic erythema of palms and soles associated with high-dose mercaptopurine chemotherapy Arch Dermatol, 1986; 122: 1413-1414.
11. MATSUYAME, J. R.; KWOK, K. K.: A variant of the chemotherapy-associated erythrodysesthesia syndrome related to high dose cyclophosphamide. DICP, 1989; 23: 776, 778-9.
12. PORTAL, I.; CARDENAL, F.; GARCÍA-DEL-MURO, X.: Etoposido-related acral erythema. Cancer Chemother Pharmacol, 1994; 34: 181.
13. LOKICH, J. J.; AHLGREN, J. D.; GULLO, J. J.; PHILIPS, J. A.; FRYER, J. R.: A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma. A Mid Atlantic Oncology Study. J Clin Oncol, 1989; 7: 425-432.
14. ROUGIER, P. H.; PAILLOT, B.; LAPLANCHE, A.; MORVAN, F.; BENHAMED, M.; SEITZ, J. F.; LAPLAIGE, P. H.; JACOB, J.; GRNDJOUAN, S.; NETTERPINON, G.; KAMIONER, D.; COMBES, M.; FABRI, M. C.; LUBOINSKI, M.; TIGAUD, J. M.: End results of a multicentric randomized trial comparing 5-FU in continous infusion to bolus administration in measurable metastatic colorectal cancer. Proc Am Soc Clin Oncol, 1992; 11: 163(Abstr. 465).
15. DE GRAMONT, A.; BASSET, J. F.; MILAN, C.; ROUGIER, P.; BOUCHÉ, O.; ETIENNE, P. L.; MORVAN, F.; LOUVET, C.; GUILLOT, T.; FRANÇOISE, E.; BEDENNE, L.: Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A french intergroup study. J Clin Oncol, 1997; 15: 808-815.
16. BANFIELD, G. K.; CRATE, I. D.; GRIFFIHS, C. L.: Long-term sequelae of Palmar-Plantar erythidysaesthesia syndrome secondary to 5-fluorouracil therapy. J R Soc Med, 1995; 88: 356-357.
17. SANMARTÍN, O.; BOTELLA, R.; GUILLEN, C.: Efectos adversos cutáneos de la quimioterapia. Piel, 1996; 11: 406-418.
18. RONGIOLETTI, F.; REBORA, A.: Eccrine squamous syringometaplasia in chemotherapy-induced acral erythema. J Am Acad Dermatol, 1992; 26: 284.
19. ZIMMERMAN, G. C.; KEELING, J. H.; LOWRY M.; MEDINA, J.; VON HOFF, D. D.; BURRIS, H. A.: Prevention of doxatel-induced erythrodysesthesia with local hypothermia. J Natl Cancer Inst, 1994; 86: 557-558.
20. ESTEVE, E.; SCHILLIO, Y.; VAILLANT, L.; BENSAID, P.; MISSONNIER, F.; METMAN, . H., LORETTE, G.: Efficacy of sequential corticotherapy in a case of painful acral erythema caused by high-dose 5-fluorouracil. Ann Med Interne Paris, 1995; 146: 192-193.